<ѻýҕl>Ozempic Overdoses; Diabetes Supplement Warning; Sen. Sanders Blames Food Industryѻýҕl> News and commentary from the endocrinology world Dec 19, 2023
<ѻýҕl>Cannabis Exposure During Pregnancy; Tirzepatide Cessation and Weight Gainѻýҕl> Also in TTHealthWatch: newer vaccine technologies in adults Dec 16, 2023 podcast
<ѻýҕl>Weight-Loss Drug Overdoses; Record Number of Retracted Studies; Yoga and Cadaversѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Dec 14, 2023
<ѻýҕl>Stopping Tirzepatide Led to Weight Gain, Trial Showsѻýҕl> But sustained treatment kept the pounds off Dec 13, 2023
<ѻýҕl>New Diabetes Care Standards; Near 40% Ditch T2D Meds; Zepbound Hits Shelvesѻýҕl> News and commentary from the endocrinology world Dec 12, 2023
<ѻýҕl>USPSTF Draft Calls for Lifestyle Shift -- Not Meds -- for Kids With Obesityѻýҕl> Behavioral interventions should be main approach; insufficient data to back pharmacologic therapy Dec 12, 2023
<ѻýҕl>Teens' High BMI Tied to Early Chronic Kidney Diseaseѻýҕl> "Enormous" risk increase seen in the highest BMI categories Dec 11, 2023
<ѻýҕl>GLP-1 Drugs Linked to Lower Colorectal Cancer Risk for Diabetes Patientsѻýҕl> Association strongest in patients with overweight, obesity Dec 07, 2023
<ѻýҕl>Doc Set Home on Fire? High Blood Pressure in Couples; WHO: Raise Alcohol, Soda Taxesѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Dec 06, 2023
<ѻýҕl>Cost Hurdles Can Keep Patients From Accessing GLP-1 Receptor Agonistsѻýҕl> Pharmacists can intervene to educate, assist with cost, two studies suggest Dec 05, 2023
<ѻýҕl>Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2Dѻýҕl> News and commentary from the endocrinology world Dec 04, 2023
<ѻýҕl>Year in Review: Obesityѻýҕl> 2023 highlights included new FDA approvals, more drugs in development, and a pivot away from BMI Dec 01, 2023
<ѻýҕl>Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosisѻýҕl> News and commentary from the endocrinology world Nov 27, 2023
<ѻýҕl>Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'dѻýҕl> News and commentary from the endocrinology world Nov 21, 2023
<ѻýҕl>Live Shingles Vaccine and Waning Immunity; Semaglutide and CV Eventsѻýҕl> Also in TTHealthWatch: sodium and blood pressure; aspirin and LVADs Nov 18, 2023 podcast
<ѻýҕl>Want Lower Obesity Drug Costs? Medicare Holds the Keyѻýҕl> Medicare coverage will catalyze market competition Nov 17, 2023
<ѻýҕl>Mall Doc Kiosks; Gaza Hospital Stormed; Rationing Semaglutide by Lifestyleѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 16, 2023
<ѻýҕl>Most Unaware of Having Prediabetes; Mid-Stage Growth Hormone Win; Fake Wegovy Woesѻýҕl> News and commentary from the endocrinology world Nov 14, 2023
<ѻýҕl>Double Defibrillator More Effective for Obese Afib Patientsѻýҕl> Clinical trial affirms a better initial strategy Nov 12, 2023
<ѻýҕl>Single-Payer Healthcare, Obesity Drug Coverage Discussed at the AMA Interim Meetingѻýҕl> Delegates agree the current system is broken but disagree on the solution Nov 12, 2023
<ѻýҕl>And for Wegovy's Next Trick, Full-Blown Cardiovascular Benefit Outside Diabetesѻýҕl> Established weight loss and diabetes drug may extend reach to millions more Nov 11, 2023
<ѻýҕl>Tirzepatide Wins FDA Approval for Weight Lossѻýҕl> Drug also gets a new brand name, Zepbound, for its new indication Nov 08, 2023
<ѻýҕl>Tone Matters in Weight-Loss Talks; Salt and Diabetes; Nix Brominated Veg Oil?ѻýҕl> News and commentary from the endocrinology world Nov 07, 2023
<ѻýҕl>Year in Review: Type 2 Diabetesѻýҕl> New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<ѻýҕl>Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancerѻýҕl> News and commentary from the endocrinology world Oct 31, 2023
<ѻýҕl>Hospitalizations With Fake Ozempic; Vosoritide OK'd for All Ages; Mounjaro for Kids?ѻýҕl> News and commentary from the endocrinology world Oct 24, 2023
<ѻýҕl>Carbohydrates and Long-Term Weight Change; Value of Cardiac Transfersѻýҕl> Also in TTHealthWatch: reducing infections in joint replacement Oct 21, 2023 podcast
<ѻýҕl>Gestational Diabetes Exposure in Utero Linked to Brain Changes in Kidsѻýҕl> These changes may contribute to an increased risk of obesity in kids, researcher says Oct 18, 2023
<ѻýҕl>Obesity Medication Type, Insurance Carrier Linked to Treatment Persistenceѻýҕl> Amount of weight lost by 6 months also played a role, according to a retrospective cohort study Oct 18, 2023
<ѻýҕl>Virtual Obesity Treatment Program Led to Substantial Weight Loss in Real-World Studyѻýҕl> At 12 months, there was an average weight loss of 16.2%, with results sustained up to 24 months Oct 17, 2023
<ѻýҕl>Certain Factors Predict Weight Regain After Big Lossesѻýҕl> But even "regainers" still kept off most of the weight Oct 17, 2023
<ѻýҕl>Regaining Weight After Bariatric Surgery Did Not Lead to Excess Mortalityѻýҕl> Weight regainers had a similar incidence of mortality as weight-loss maintainers Oct 17, 2023
<ѻýҕl>Semaglutide's Weight-Loss Benefit Also Seen in Patients on Antidepressantsѻýҕl> Those on antidepressants lost an average 11% to 19% of body weight across the four STEP trials Oct 16, 2023
<ѻýҕl>Tirzepatide Has Huge Impact on Weight, Even After Loss From Lifestyle Changeѻýҕl> Trial participants lost over a fifth of their body weight atop diet, exercise-induced losses Oct 16, 2023
<ѻýҕl>Mental Health Warning Signs in Latinx Kids Tied to Cardiometabolic Risksѻýҕl> Signs of depression, anxiety in middle school linked with troubles by high school Oct 16, 2023
<ѻýҕl>Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Testѻýҕl> News and commentary from the endocrinology world Oct 10, 2023
<ѻýҕl>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Saysѻýҕl> Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<ѻýҕl>Weight-Loss Drug Benefit Spans HFpEF, HFmrEFѻýҕl> STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
<ѻýҕl>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻýҕl> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻýҕl>Are Obesity Drugs for Adolescents Cost-Effective?ѻýҕl> Despite the effectiveness of these medications, costs are a major barrier Sep 30, 2023